Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.

Dupre KB, Ostock CY, George JA, Eskow Jaunarajs KL, Hueston CM, Bishop C.

ACS Chem Neurosci. 2013 May 15;4(5):747-60. doi: 10.1021/cn300234z. Epub 2013 Apr 1.

2.

Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.

Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD.

J Neurosci Res. 2009 May 15;87(7):1645-58. doi: 10.1002/jnr.21978.

3.

Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

Dupre KB, Eskow KL, Barnum CJ, Bishop C.

Neuropharmacology. 2008 Dec;55(8):1321-8. doi: 10.1016/j.neuropharm.2008.08.031. Epub 2008 Sep 10.

4.

Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.

Dupre KB, Ostock CY, Eskow Jaunarajs KL, Button T, Savage LM, Wolf W, Bishop C.

Exp Neurol. 2011 Jun;229(2):288-99. doi: 10.1016/j.expneurol.2011.02.012. Epub 2011 Feb 22.

5.

Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.

Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.

Brain Res. 2013 Nov 6;1537:327-39. doi: 10.1016/j.brainres.2013.09.020. Epub 2013 Sep 21.

6.

Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.

Dupre KB, Eskow KL, Steiniger A, Klioueva A, Negron GE, Lormand L, Park JY, Bishop C.

Psychopharmacology (Berl). 2008 Jul;199(1):99-108. doi: 10.1007/s00213-008-1135-6. Epub 2008 Jun 11.

PMID:
18545986
7.

Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.

Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, Walker PD, Bishop C.

Neuropharmacology. 2011 Sep;61(4):753-60. doi: 10.1016/j.neuropharm.2011.05.021. Epub 2011 May 27.

8.

Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.

Iderberg H, Rylander D, Bimpisidis Z, Cenci MA.

Exp Neurol. 2013 Dec;250:116-24. doi: 10.1016/j.expneurol.2013.09.003. Epub 2013 Sep 10.

PMID:
24029003
9.
11.

Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.

Jaunarajs KL, Dupre KB, Steiniger A, Klioueva A, Moore A, Kelly C, Bishop C.

Neuroreport. 2009 Sep 23;20(14):1265-9. doi: 10.1097/WNR.0b013e3283300fd7.

PMID:
19633584
12.

A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease.

Tomiyama M, Kimura T, Maeda T, Kannari K, Matsunaga M, Baba M.

Neurosci Res. 2005 Jun;52(2):185-94. Epub 2005 Apr 13.

PMID:
15893579
14.

Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.

Byrnes EM, Reilly A, Bruno JP.

Synapse. 1997 Jul;26(3):254-68.

PMID:
9183815
15.

In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.

Mela F, Marti M, Bido S, Cenci MA, Morari M.

Neurobiol Dis. 2012 Jan;45(1):573-82. doi: 10.1016/j.nbd.2011.09.015. Epub 2011 Oct 7.

PMID:
22001605
16.

Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.

Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.

Synapse. 2008 Jul;62(7):524-33. doi: 10.1002/syn.20527. Erratum in: Synapse. 2008 Dec;62(12):958. Lucia, Frau [corrected to Frau, Lucia]; Annalisa, Pinna [corrected to Pinna, Annalisa]; Silvia, Pontis [corrected to Pontis, Silvia]; Nicola, Simola [corrected to Simola, Nicola]; Nicoletta, Schintu [corrected to Schintu, Nicoletta]; Micaela, Morelli [corrected to Morelli, Micaela].

PMID:
18435422
17.

Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.

Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A.

Neuropharmacology. 2015 Jun;93:52-67. doi: 10.1016/j.neuropharm.2015.01.012. Epub 2015 Jan 31.

PMID:
25645393
18.

The theta-related firing activity of parvalbumin-positive neurons in the medial septum-diagonal band of Broca complex and their response to 5-HT1A receptor stimulation in a rat model of Parkinson's disease.

Li LB, Han LN, Zhang QJ, Sun YN, Wang Y, Feng J, Zhang L, Wang T, Chen L, Liu J.

Hippocampus. 2014 Mar;24(3):326-40. doi: 10.1002/hipo.22226. Epub 2013 Nov 26.

PMID:
24174292
19.
20.

Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.

Ba M, Kong M, Ma G, Yang H, Lu G, Chen S, Liu Z.

Brain Res. 2007 Jan 5;1127(1):177-84. Epub 2006 Nov 17.

PMID:
17113046
Items per page

Supplemental Content

Write to the Help Desk